Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.
Recent performance snapshot
With no single headline event driving attention, British American Tobacco (LSE:BATS) has come into focus after a period where the stock delivered a 10.6% year to date return and a 62.5% total return over the past year.
See our latest analysis for British American Tobacco.
The current £46.34 share price sits against a backdrop of strong recent momentum, with a 7.6% 7 day share price return and a 62.5% 1 year total shareholder return indicating that sentiment has shifted meaningfully over the past year.
If this kind of rebound has you thinking about what else could be setting up for strong returns, it is worth scanning the market for under the radar strength in 5 top founder-led companies
After such a strong run and with British American Tobacco trading close to analyst price targets but at an indicated intrinsic discount, is the stock still undervalued, or is the market already pricing in future growth?
Most Popular Narrative: 22.1% Undervalued
According to the most followed narrative, British American Tobacco’s fair value of £59.46 sits well above the recent £46.34 share price, which is what anchors the current undervaluation argument.
BAT’s majority-owned affiliates in Bangladesh (73%), Malaysia (50%), Kenya (60%), and Zambia (75%), with each of them already having the minority shares listed on local stock markets (see also their listing in Simply Wall Street), illustrate its strategic focus on emerging markets. And if you like it or not: even with them still focusing primarily on tobacco-related business, the floating of the shares on local exchanges is good news for the development of the financial sector in those countries.
Want to see how a consumer goods tilt, higher margin assumptions, stronger revenue growth and a richer future P/E multiple all connect into that higher fair value? The full narrative by evd101 lays out the detailed projections and the logic tying these moving parts together, step by step.
Result: Fair Value of £59.46 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, this thesis could be knocked off course if regulation tightens around nicotine products, or if emerging market partners underperform and weaken the consumer goods story.
Find out about the key risks to this British American Tobacco narrative.
Next Steps
With both risks and rewards now on the table, do the signals around British American Tobacco stack up for you or raise fresh questions? Take a moment to review the details, pressure test the assumptions, and then decide where you stand after weighing the 3 key rewards and 2 important warning signs.
Looking for more investment ideas?
If British American Tobacco has sharpened your focus, do not stop here. The market is full of stocks with very different risk and return profiles worth examining next.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BATS.L.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com